» Articles » PMID: 15526837

Treatment of Advanced Non-small-cell Lung Cancer in Special Populations

Overview
Specialty Oncology
Date 2004 Nov 6
PMID 15526837
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The benefits of chemotherapy in non-small-cell lung cancer (NSCLC) patients remains, to some extent, restricted to younger patients with a good performance status (PS). It has long been assumed that chemotherapy is too toxic and of marginal benefit for elderly NSCLC patients and those with a PS of 2. Nevertheless, retrospective analyses and more recent prospective trials have suggested that such patients enjoy longer survival and a better quality of life when treated with chemotherapy. This article will review the data and discuss their clinical implications.

Citing Articles

Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?.

Malapelle U, Rossi A, Bria E J Thorac Dis. 2019; 11(Suppl 15):S1837-S1840.

PMID: 31632763 PMC: 6783785. DOI: 10.21037/jtd.2019.08.99.


The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma.

Choi J, Choi J, Chung S, Oh J, Lee Y, Min K Tuberc Respir Dis (Seoul). 2019; 82(3):211-216.

PMID: 30841020 PMC: 6609518. DOI: 10.4046/trd.2018.0019.


Factors influencing treatment selection and survival in advanced lung cancer.

Tabchi S, Kassouf E, Florescu M, Tehfe M, Blais N Curr Oncol. 2017; 24(2):e115-e122.

PMID: 28490934 PMC: 5407874. DOI: 10.3747/co.24.3355.


Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Fujimoto D, Kato R, Morimoto T, Shimizu R, Sato Y, Kogo M PLoS One. 2016; 11(12):e0168465.

PMID: 28006019 PMC: 5179067. DOI: 10.1371/journal.pone.0168465.


ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.

Noronha V, Ramaswamy A, Patil V, Joshi A, Chougule A, Kane S PLoS One. 2016; 11(9):e0160752.

PMID: 27637025 PMC: 5026380. DOI: 10.1371/journal.pone.0160752.